A novel contrast-induced acute kidney injury model based on the 5/6-nephrectomy rat and nephrotoxicological evaluation of iohexol and iodixanol in vivo

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Liu, Tong Qiang ^a,b   Luo, Wei Li ^a   Tan, Xiao ^a   Fang, Yi ^a,c   Chen, Jing ^a   Zhang, Hui ^a   Yu, Xiao Fang ^a,c   Cai, Jie Ru ^a   Ding, Xiao Qiang ^a,c  

^a FUDAN UNIVERSITY   (China)

^b THE AFFILIATED CHANGZHOU NO 2 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Shanghai Institute of Kidney and Dialysis   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DEHYDRATION; RATS;

ANIMAL MODEL; INJURY MODELS; IODINATED CONTRAST MEDIA; PRE-TREATMENT; RENAL FUNCTIONS; RENAL TISSUE; TOXIC EFFECT; TUBULAR CELLS;

CONTRAST MEDIA;

IODIXANOL; IOHEXOL; CONTRAST MEDIUM; IODOBENZOIC ACID DERIVATIVE;

ABLATION THERAPY; ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTROLLED STUDY; DEHYDRATION; HYPOXIA; IN VIVO STUDY; INFLAMMATION; KIDNEY FUNCTION; KIDNEY PARENCHYMA; MALE; NEPHRECTOMY; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; URINE VOLUME; ANIMAL; BLOOD; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; KIDNEY; PATHOLOGY; PROCEDURES; RANDOMIZATION; SPRAGUE DAWLEY RAT; SURGERY; URINE;

RATTUS;

ACUTE KIDNEY INJURY; ANIMALS; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; IOHEXOL; KIDNEY; MALE; NEPHRECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TRIIODOBENZOIC ACIDS;

EID: 84912116177     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/427560     Document Type: Article

References (32)

1. Seeliger E., Sendeski M., Rihal C. S., Persson P. B., Contrast-induced kidney injury: mechanisms, risk factors, and prevention. European Heart Journal 2012 33 16 2007 2015 10.1093/eurheartj/ehr494 2-s2.0-84865212795
2. Kodama A., Watanabe H., Tanaka R., Tanaka H., Chuang V. T. G., Miyamoto Y., Wu Q., Endo M., Hamasaki K., Ishima Y., Fukagawa M., Otagiri M., Maruyama T., A human serum albumin-thioredoxin fusion protein prevents experimental contrast-induced nephropathy. Kidney International 2013 83 3 446 454 2-s2.0-84874659901 10.1038/ki.2012.429
3. Jorgensen A. L., Contrast-induced nephropathy: pathophysiology and preventive strategies. Critical Care Nurse 2013 33 1 37 46 10.4037/ccn2013680 2-s2.0-84873437589
4. Guastoni C., Bellotti N., Poletti F., Covella P., Gidaro B., Stasi A., Seveso G., D'Urbano M., Mariani M., De Servi S., Continuous venovenous hemofiltration after coronary procedures for the prevention of contrast-induced acute kidney injury in patients with severe chronic renal failure. The American Journal of Cardiology 2014 113 4 588 592 10.1016/j.amjcard.2013.10.037 2-s2.0-84895070273
5. Duarte C. G., Zhang J., Ellis S., The SHR as a small animal model for radiocontrast renal failure. Relation of nephrotoxicity to animal's age, gender, strain, and dose of radiocontrast. Renal Failure 1997 19 6 723 743 2-s2.0-0031456513 10.3109/08860229709037213
6. Ari E., Yilmaz Y., Kedrah A. E., Alahdab Y., Cakalagaoglu F., Arikan H., Kocak H., MacUnluoglu B., Atakan A., Kahveci A., Asicioglu E., Tuglular S., Ozener C., Protective effect of the vasopressin agonist terlipressin in a rat model of contrast-induced nephropathy. American Journal of Nephrology 2011 33 3 269 276 2-s2.0-79952101944 10.1159/000324764
7. Ozkan G., Ulusoy S., Orem A., Ersoz S., Alkanat M., Yucesan F. B., Kaynar K., Al S., Protective effect of the grape seed proanthocyanidin extract in a rat model of contrast-induced nephropathy. Kidney and Blood Pressure Research 2013 35 6 445 453 10.1159/000337926 2-s2.0-84861793625
8. Efrati S., Berman S., Ilgiyeav I., Siman-Tov Y., Averbukh Z., Weissgarten J., Differential effects of N-acetylcysteine, theophylline or bicarbonate on contrast-induced rat renal vasoconstriction. The American Journal of Nephrology 2009 29 3 181 191 10.1159/000154471 2-s2.0-51049083848
9. Wu C. T., Weng T. I., Chen L. P., Chiang C. K., Liu S. H., Involvement of caspase-12-dependent apoptotic pathway in ionic radiocontrast urografin-induced renal tubular cell injury. Toxicology and Applied Pharmacology 2013 266 1 167 175 10.1016/j.taap.2012.10.012 2-s2.0-84871860004
10. Sun S., Zhang T., Nie P., Hu L., Yu Y., Cui M., Cai Z., Shen L., He B., A novel rat model of contrast-induced acute kidney injury. International Journal of Cardiology 2014 172 1 e48 e50 2-s2.0-84894095364 10.1016/j.ijcard.2013.12.066
11. Jensen H., Doughty R. W., Grant D., Myhre O., A modified model of gentamicin induced renal failure in rats: toxicological effects of the iodinated X-ray contrast media ioversol and potential usefulness for toxicological evaluation of iodinated X-ray contrast media. Experimental and Toxicologic Pathology 2013 65 5 601 607 10.1016/j.etp.2012.06.003 2-s2.0-84878376207
12. Ackland P., Prevalence, detection, evaluation and management of chronic kidney disease. British Medical Journal 2014 348 10.1136/bmj.f7688
13. Zhang L., Wang F., Wang L., Wang W., Liu B., Liu J., Chen M., He Q., Liao Y., Yu X., Chen N., Zhang J.-E., Hu Z., Liu F., Hong D., Ma L., Liu H., Zhou X., Chen J., Pan L., Chen W., Li X., Wang H., Prevalence of chronic kidney disease in China: a cross-sectional survey. The Lancet 2012 379 9818 815 822 10.1016/S0140-6736(12)60033-6 2-s2.0-84863230493
14. Griffin K. A., Bidani A. K., Ouyang J., Ellis V., Churchill M., Churchill P. C., Role of endothelium-derived nitric oxide in hemodynamic adaptations after graded renal mass reduction. American Journal of Physiology 1993 264 6, part 2 R1254 R1259 2-s2.0-0027298775
15. Griffin K. A., Picken M., Bidani A. K., Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury. Journal of the American Society of Nephrology 1994 4 12 2023 2031 2-s2.0-0028451064
16. Racusen L. C., Solez K., Nephrotoxic tubular and interstitial lesions: morphology and classification. Toxicologic Pathology 1986 14 1 45 57 10.1177/019262338601400106 2-s2.0-0022531059
17. Idée J.-M., Bonnemain B., Reliability of experimental models of iodinated contrast media-induced acute renal failure: From methodological considerations to pathophysiology. Investigative Radiology 1996 31 4 230 241 10.1097/00004424-199604000-00008 2-s2.0-0029988332
18. Ware K., Brodsky P., Satoskar A. A., Nadasdy T., Nadasdy G., Wu H., Rovin B. H., Bhatt U., Von Visger J., Hebert L. A., Brodsky S. V., Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. Journal of the American Society of Nephrology 2011 22 10 1856 1862 10.1681/ASN.2010101110 2-s2.0-80053491983
19. Jiang Y., Wang M., Hyperphosphatemia-induced hyperparathyroidism in 5/6 nephrectomized rats: development of a new animal model. Chinese Medical Journal 2008 121 23 2440 2443 2-s2.0-63149180474
20. Fukunaga N., Takahashi N., Hagiwara S., Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress. Heart Rhythm 2012 9 12 2023 2031 10.1016/j.hrthm.2012.08.019 2-s2.0-84870433256
21. Krause W., In vitro and animal experiments in contrast media testing. Investigative Radiology 1998 33 3 182 191 10.1097/00004424-199803000-00009 2-s2.0-0031978901
22. Solez K., Racusen L. C., Olsen S., The pathology of drug nephrotoxicity. The Journal of Clinical Pharmacology 1983 23 10 484 490 2-s2.0-0021082163 10.1002/j.1552-4604.1983.tb01794.x
23. Jost G., Lengsfeld P., Lenhard D. C., Pietsch H., Hütter J., Sieber M. A., Viscosity of iodinated contrast agents during renal excretion. European Journal of Radiology 2011 80 2 373 377 10.1016/j.ejrad.2011.02.003 2-s2.0-80053619710
24. Seeliger E., Flemming B., Wronski T., Ladwig M., Arakelyan K., Godes M., Möckel M., Persson P. B., Viscosity of contrast media perturbs renal hemodynamics. Journal of the American Society of Nephrology 2007 18 11 2912 2920 10.1681/ASN.2006111216 2-s2.0-35848933242
25. Solomon R., Contrast media: are there differences in nephrotoxicity among contrast media? BioMed Research International 2014 2014 8 934947 2-s2.0-84893749022 10.1155/2014/934947
26. Palm F., Carlsson P.-O., Fasching A., Effects of the contrast medium iopromide on renal hemodynamics and oxygen tension in the diabetic rat kidney. Advances in Experimental Medicine and Biology 2003 530 653 659 10.1007/978-1-4615-0075-9-65 2-s2.0-0242267150
27. Seeliger E., Cantow K., Arakelyan K., Ladwig M., Persson P. B., Flemming B., Low-dose nitrite alleviates early effects of an X-ray contrast medium on renal hemodynamics and oxygenation in rats. Investigative Radiology 2014 49 2 70 77 10.1097/RLI.0b013e3182a6fea6 2-s2.0-84893685470
28. Wong P. C. Y., Li Z., Guo J., Zhang A., Pathophysiology of contrast-induced nephropathy. International Journal of Cardiology 2012 158 2 186 192 10.1016/j.ijcard.2011.06.115 2-s2.0-84862226378
29. Jensen H., Doughty R. W., Grant D., Myhre O., The effects of the iodinated X-ray contrast media iodixanol, iohexol, iopromide, and ioversol on the rat kidney epithelial cell line NRK 52-E. Renal Failure 2011 33 4 426 433 10.3109/0886022X.2011.568146 2-s2.0-79955613674
30. Aspelin P., Aubry P., Fransson S.-G., Strasser R., Willenbrock R., Berg K. J., Nephrotoxic effects in high-risk patients undergoing angiography. The New England Journal of Medicine 2003 348 6 491 499 10.1056/NEJMoa021833 2-s2.0-0037421597
31. Heinrich M. C., Häberle L., Müller V., Bautz W., Uder M., Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology 2009 250 1 68 86 10.1148/radiol.2501080833 2-s2.0-58149331038
32. Barrett B. J., Katzberg R. W., Thomsen H. S., Chen N., Sahani D., Soulez G., Heiken J. P., Lepanto L., Ni Z.-H., Nelson R., Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Investigative Radiology 2006 41 11 815 821 10.1097/01.rli.0000242807.01818.24 2-s2.0-33749832938